Podcasts about medstar georgetown university hospital

Send us a textAccording to the CDC, an estimated 58.5 million US adults have been diagnosed with some type of arthritis. Arthritis Awareness Month is observed every May, and it's a time to inform people about this complex group of debilitating diseases. The goal of this episode is to educate listeners about the impact of arthritis, how to promote lifestyle changes for prevention, and highlight the importance of research and support for those living with the condition. To do that, we're joined by Dr. Michael Kessler, Chief - Division of Hand & Elbow Surgery in the Department of Orthopaedic Surgery at MedStar Georgetown University Hospital.For an interview with Dr. Michael Kessler, or for more information about this podcast, contact MedStar Georgetown University Hospital Manager Media Relations, Ryan.M.Miller2@Medstar.net.Learn more about Dr. Kessler. For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

In this episode of the Dr. Geo Prostate Podcast, we welcome Dr. Jonathan Lischalk, Director of Genitourinary Cancers at MedStar Georgetown University Hospital and former Medical Director at NYU's NYCyberKnife Center. Dr. Lischalk breaks down the evolution of radiation oncology and how cutting-edge imaging and targeted SBRT (Stereotactic Body Radiation Therapy) are reshaping prostate cancer treatment.We explore how imaging advances like MRI and PSMA PET scans are enabling unprecedented precision, the future of genetic-based personalization in prostate cancer therapy, and why fewer, more focused radiation sessions might soon become the new standard. From understanding the biology of radiation dosing to upcoming trials eliminating ADT in select patients, this is a must-listen for anyone looking to stay informed on the forefront of cancer care.

In this Leveling Up episode of the PRS Global Open Deep Cuts podcast, Dr. Christopher Attinger discusses how to build a successful wound center, the benefits of including psychiatry in a wound care service, the importance of removing all indurated tissues during a debridement, why placing a skin graft on granulation tissue is actually a bad idea, the benefits of bypass surgery over angioplasty, how to know when Integra has good take, his go-to local flaps for the foot and ankle and why he doesn't like reverse sural flaps. He also discusses the nuances of performing a TMA and a BKA, why he never uses deep sutures in any wound closure, how TMR has been a game changer in his practice, the rating system for medial arterial calcinosis that predicts the risk of complications, and how he has structured the service to maximize resident education. Read a classic PRS Global Open article by Dr. Attinger and his colleagues, “The Effect of Positive Postdebridement Cultures on Local Muscle Flap Reconstruction of the Lower Extremity”: https://bit.ly/DebridementFXLE  Dr. Christopher Attinger is a Professor in the Plastic and Reconstructive Surgery Department at Georgetown University Medical Center, and the Director of the Center for Wound Healing at MedStar Georgetown University Hospital. He served two tours of duty in Vietnam, as a lieutenant in the 82nd Airborne and the 101st Airborne divisions, and was honorably discharged with a Purple Heart and Bronze Star. He received his medical degree from Yale University, and then completed a residency in general surgery and fellowship in vascular surgery at Brigham and Women's Hospital in Boston, and a plastic surgery residency and hand surgery fellowship at New York University. After completing his training, he joined the faculty at Georgetown, and has been there ever since. In 2007, Dr. Attinger started an annual limb salvage conference to bring together all the members of the limb salvage community to exchange ideas and innovations.  Your host, Dr. Puru Nagarkar, is a board-certified plastic and hand surgeon, and Associate Professor of Plastic Surgery at the University of Texas Southwestern Medical Center in Dallas. The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS. #PRSGlobalOpen #DeepCutsPodcast #PlasticSurgery #LevelingUp

Who Is That Girl in The Mirror?  It is challenging for women to see changes to their bodies during and after treatment. Some have to cope with hair loss, others with changes to skin tone and texture, many others with scars from lumpectomy or mastectomy, with or without reconstruction which adds another layer of complexity to an already difficult cancer diagnosis. Hear from Heather and Lauren Spiezia who have experienced this firsthand, Yonni and Jana Siegel as caregivers and friends, and Dr. Lucy de la Cruz as a breast surgeon about handling side-effects, cold-capping, managing surgical expectations and more. Episode 3 Guest Bios: Lauren Spiezia: Lauren Spiezia is a passionate advocate and breast cancer warrior, diagnosed in 2024 at the age of 31. Despite still undergoing treatment, she is dedicated to sharing her journey with others, offering strength and insight to those in similar battles. Professionally, Lauren brings a wealth of experience in wealth management, coupled with a strong entrepreneurial spirit. Following her diagnosis, she was inspired to launch a venture in clean, non-toxic cosmetics, reflecting her commitment to health and wellness both personally and professionally. Outside of her cancer journey and business endeavors, Lauren enjoys spending time with her husband and 2-year-old son in New Jersey. A former collegiate athlete at Babson College, she continues to prioritize an active lifestyle, valuing health in all aspects of her life. Jana Shopkorn Siegel: Jana Shopkorn Siegel is a New York State licensed speech-language pathologist who earned her Bachelor's and Master's degrees in Child Development from Tufts University before going on to receive her Master of Arts in Speech-Language Pathology from NYU. She has worked in a wide range of settings, including schools, daycares, homes, and virtual platforms with diverse populations, and in private practice as well. Jana is passionate about helping individuals of all ages find their voice and build confidence through communication. She holds a Certificate of Clinical Competence from the American Speech-Language-Hearing Association (ASHA) and is a proud member of the organization. Jana was born and raised in NYC and lives there with her husband and three teenagers. She is involved with the Ronald McDonald House, and supports other charities that have touched her life and community.  Dr. Lucy de la Cruz: Dr. Lucy De La Cruz is an internationally recognized breast surgical oncologist and the Chief of Breast Surgery at MedStar Georgetown University Hospital. She serves as the Director of the Lombardi Betty Lou Ourisman Breast Health Center and is an Associate Professor of Surgery at Georgetown University School of Medicine. Dr. De La Cruz is deeply committed to advancing women's health through personalized, compassionate care, innovative treatment, and education. Her pivotal manuscript on nipple-sparing and oncoplastic surgical outcomes has been widely cited and continues to shape the global landscape of breast surgery for both patients and physicians. Known for blending surgical precision with empathy and advocacy, she brings a powerful voice to conversations around leadership, equity, and the evolving role of women in medicine and beyond. Dr. De La Cruz's unique perspective is shaped by her experience as a surgeon, mother, and mentor—blending clinical excellence with heart, humor, and humanity. Find Yonni & Heather here https://www.herhealthcompass.com/

Send us a textMarch is Colorectal Cancer Awareness Month. Colorectal cancer is the fourth most commonly diagnosed cancer in the U.S. and the second leading cause of cancer deaths. Yet this cancer can be prevented with screening and is highly treatable when detected early. On this episode of our DocTalk podcast, we're discussing colon cancer with Dr. Walid Chalhoub, the Division Chief of Gastroenterology at MedStar Southern Maryland Hospital Center, and the Co-Director of Advanced Endoscopy at MedStar Georgetown University Hospital. Dr. Chalhoub discusses the difference between gastroenterology and advanced gastroenterology, and how getting a colonoscopy can save your life.For an interview with Dr. Walid Chalhoub, or for more information about this podcast, contact MedStar Georgetown University Hospital Manager Media Relations, Ryan.M.Miller2@Medstar.net.Learn more about Dr. Chalhoub. For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

In this Leveling Up episode of the PRS Global Open Deep Cuts podcast, Dr. David Song discusses several key topics. He highlights the unique role that plastic surgeons can play as leaders within surgery and the broader medical system. Dr. Song emphasizes that being an excellent clinician with "street cred" is essential for effective leadership. He also talks about how to create and guide change effectively, and the importance of active listening in both surgery and patient care. Additionally, Dr. Song shares insights on preoperative and anesthetic modifications that can improve patient recovery after microsurgery. He explains why he always uses two separate venous systems in a DIEP flap and provides technical details on arterial anastomosis. He also discusses the latissimus immediate fat transfer flap for non-microsurgical autologous breast reconstruction. Finally, Dr. Song reflects on how being right and cultivating durable relationships can sometimes be at odds with each other. Read a classic PRS Global Open article by Dr. Song and Dr. James Economides, “Latissimus Dorsi and Immediate Fat Transfer (LIFT) for Complete Autologous Breast Reconstruction:”  https://bit.ly/LIFT_Breast_Recon_GOX Dr. David Song is the Chief Medical Officer and Vice President of Medical Affairs for MedStar Georgetown University Hospital, as well as a Professor and former Chairman of the Department of Plastic Surgery, and the former Chief of Surgery at Georgetown University School of Medicine. He completed residencies in general surgery and plastic surgery as well as a microsurgery fellowship at the University of Chicago, where he stayed on first as a faculty member, and then as the Chief of Plastic Surgery. He moved to Georgetown to become the Chair of Plastic Surgery in 2017, before recently moving into the role of Chief Medical Officer and VP of Medical Affairs. Among his many leadership roles in plastic surgery, he is a former President of the American Society of Plastic Surgeons, former Chair of the American Board of Plastic Surgery, and current chair of the ACGME Plastic Surgery Residency Review Committee. Your host, Dr. Puru Nagarkar, is a board-certified plastic and hand surgeon, and Associate Professor of Plastic Surgery at the University of Texas Southwestern Medical Center in Dallas. #PRSGlobalOpen #DeepCutsPodcast #PlasticSurgery #LevelingUp

Episode 041 | ***Please note that this episode was recorded in October 2024 and is being published on January 16, 2025. Dr. Swigost's tale has evolved in some big ways since that time, including the announcement of the imminent closure of Dapper Dermatology in Austin, TX on 2/28/2025. Adam shared with me that he has no regrets about this experience, and I believe it. He's undoubtedly more prepared now than ever to serve his patients in the way that suits him best. (Suits! Dapper! The PUNisher, Dr. Aamir Hussain, will hopefully appreciate this.) If you love him like I do and want to know more, stay tuned for future episodes or reach out to him directly to say hello. Now on with the show!***  Dr. Adam Swigost is a board-certified dermatologist and entrepreneur. He founded Dapper Dermatology, which started as North Dakota's first and only entirely virtual dermatology clinic and evolved into a full service direct care dermatology clinic located in Austin, TX (closing 2/28/2025 as discussed above). Above all, Dr. Swigost is an advocate for physician autonomy and reinvigorating the patient-physician relationship, and he will no doubt bring an outstanding and innovative suite of services to wherever he is headed next.He completed his undergraduate degrees and medical training at the University of North Dakota. He completed his internship through the University of Central Florida in Ocala, FL, and his dermatology residency at Medstar Georgetown University Hospital and Washington Hospital Center in Washington, DC. He is a member of the American Academy of Dermatology, the American Society for Dermatologic Surgery, and the Gay and Lesbian Dermatology Association.If you aren't one of the 186 people (or 86 people plus my mom 100 times -- thanks, Ma!) who have listened to Episode 004 published on January 11th, 2024 back when the show was still called The Direct Care Derm, I highly recommend you check that out first and then come back to this episode. You'll have fun learning about Dr. Swigost's origin story, and you'll get to hear me suck at podcasting way more than I do now. Win-win! I hope you enjoy the show(s).Connect with Dr. SwigostDapper Dermatology Instagram info@dapperdermatology.comMore from Dr. Lewellis and Above & Beyond DermatologyNeed a dermatologist? Fill out this short interest form, text or call me at 715-391-9774, or email me at drlewellis@aboveandbeyondderm.com if you'd like to have a no obligation discovery call. I offer in-office visits, house calls, and virtual care in Wisconsin and virtual care in Illinois, Nebraska, and Colorado.Have an idea for a guest or want to be on the show yourself? Send me a text or email, and we'll see if it's a good fit.

Step into the fascinating world of plastic surgery with Dr. Ilana Margulies, a PGY5 integrated plastic surgery resident at MedStar Georgetown University Hospital. In this episode, Dr. Margulies shares her journey through medicine, blending technical mastery with a deep understanding of psychology to transform lives through plastic surgery. Dr. Margulies sheds light on the complexity of the field, from aesthetic and reconstructive procedures to the intricate art of microsurgery. She explains how plastic surgery isn't just about physical transformation but also involves addressing the emotional and psychological needs of patients. The conversation delves into her groundbreaking research, her leadership roles within the Plastic and Reconstructive Surgery Journal's Resident Advisory Board, and her vision for a career in general and complex microsurgical reconstruction. This episode is a must-listen for anyone curious about the blend of science, art, and humanity that defines plastic surgery. Tune in for an enlightening discussion that goes beyond the surface and into the heart of what makes this field so unique. Ilana Margulies, MD, MS is a PGY5 integrated plastic surgery resident at MedStar Georgetown University Hospital in Washington, DC. She completed her undergraduate studies in Biology with honors at New York University and then completed a Masters in Biomedical Sciences at the Icahn School of Medicine at Mount Sinai. She then earned her MD at New York Medical College with Global and Population Health Area of Distinction, and was inducted into the Alpha Omega Alpha Honors Medical Society. During medical school she pursued a research fellowship in plastic surgery at the Icahn School of Medicine at Mount Sinai. She has authored over 30 peer reviewed publications and presented at numerous conferences. She is also very involved in the resident advisory board of the Plastic and Reconstructive Surgery Journal and the Jewish Plastic Surgeons Forum. She hopes to pursue a career in general and complex microsurgical reconstruction. When out of the hospital, she enjoys spending time with her husband, two daughters, and golden retriever. _________________________________________________ Sponsor the JOWMA Podcast! Email digitalcontent@jowma.org Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

Send us a textLung cancer is the leading cause of cancer deaths in both men and women, resulting in more cancer deaths than breast, prostate, and colorectal cancers combined. It can take years to develop and is difficult to detect in early stages when there is greater potential for a cure. Fortunately, lung cancer survival rates are improving, thanks to advances in screening and treatment options, including breakthrough therapies that we're leading at MedStar Health. In partnership with the Georgetown Lombardi Comprehensive Cancer Center—a National Cancer Institute-designated comprehensive cancer center—we can offer our patients promising clinical trials years before they become the standard of care. Dr. Edward Chan is the Chief of Thoracic Surgery at MedStar Washington Hospital Center. Dr. Chan sees patients at MedStar Washington Hospital Center and MedStar Georgetown University Hospital. Dr. Chan is double-board certified and specializes in general thoracic surgery. He treats patients for lung cancer, esophageal cancer, benign esophageal diseases (such as acid reflux/hiatal hernia and achalasia), and mediastinal tumors. For an interview with Dr. Edward Chan, or for more information about this podcast, contact MedStar Georgetown University Hospital Manager Media Relations, Ryan.M.Miller2@Medstar.net.  Learn more about Dr. Chan. For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Our next guest is Kyle Swinsky, CEO of AMOpportunities. Kyle leads a company that helps medical trainees, students, and international graduates secure rotations in the US. Kyle's company mission is to help improve the US health system by unveiling the importance of foreign-trained physicians and the impact of US clinical experiences for international medical students/graduates across the world.   Kyle Swinsky is the co-founder and CEO of AMOpportunities, a Chicago-based company that helps international medical students and graduates secure U.S. rotations and supports hospitals and schools in managing trainees through high-quality services and software solutions.   Connect with Kyla and AMOpportunities Here https://www.linkedin.com/in/kyleswinsky/ https://amopportunities.org/ https://www.youtube.com/channel/UC-xw8Mr2bu7bvD6PTezy0YQ In 2013, Kyle, along with co-founder and COO Ben Bradley, launched AMOpportunities to make U.S. clinical experiences accessible to medical trainees around the world. Since 2013, AMO has tripled in size, raised $8.9 million in funding, won the President's “E” Award for Exports and PIEoneer of the Year, and helped more than 3,600 trainees rotate in the U.S.   The company counts Kaplan Medical and AMSA as partners as well as institutions such as University of Miami, Chicago Medicine, MedStar Georgetown University Hospital, and Florida International University.   © Concierge Medicine Today, LLC. ("CMT") All rights reserved.   Disclaimers: All content presented here is for general information purposes only. It is NOT intended to provide medical, legal, professional, accounting or financial advice. No warranties or guarantees are assumed or implied and user(s) releases Concierge Medicine Today, LLC, its agents, representatives, affiliated brands/companies and/or guests from all damages, liability and/or claims. Be advised, some references, companies, individuals, products, services, resources and/or links may be out-of-date. Concierge Medicine Today, LLC does not update content past its release date. User(s) assume all risk and liability with any use of the content as well as third party links. Concierge Medicine Today, LLC., has no formal peer review and, therefore, cannot guarantee the validity of information and/or content contained on its web sites, podcasts, and/or all content it produces or releases. While some of our speakers may be licensed Physicians, they are not your Physician. Please consult your Physician related to anything you may have read or heard or have questions about or call 911. The views, thoughts, and opinions expressed are the speaker's own and do not necessarily represent the views, thoughts, and/or opinions of Concierge Medicine Today, LLC. The "Concierge Medicine Today, LLC" ("CMT") name and all forms and abbreviations are the property of its owner and its use does not imply endorsement of or opposition to any specific organization, product, or service. Additional disclaimers, releases, terms of use and conditions apply also to the production and/or use of this content, https://conciergemedicinetoday.org/tcpp/.

We'd love to hear from you about this episode.Mental health is a topic that we hear about often. Managing the mental dimension of wellness is essential at every stage of life, from childhood and adolescence through adulthood.It is estimated that nearly 20 million of our nation's young people can currently be diagnosed with a mental health disorder. The U.S. Department of Health and Human Services stated that 1 in 5 U.S. children (ages 3–17) has a mental, emotional, behavioral, or developmental disorder. Many more are at risk of developing a disorder due to biological, family, school, ecological, political, peer, and community risk factors. Our relationship with the natural world is critical in supporting good mental health and preventing mental and emotional distress.Welcome to Episode Forty-Four of The Nature of Wellness Podcast.  In this episode, we sat down with Dr. Matthew Biel, Chief of the Division of Child and Adolescent Psychiatry at MedStar Georgetown University Hospital and a Professor of Clinical Psychiatry and Pediatrics at Georgetown University School of Medicine. Join us as we speak to Matt about how he interacts with the natural world, how time in nature can be a powerful mental health service,  and how one's environment plays a vital role in developing and maintaining a child's mental well-being. Matt discusses the impact of adversity and stress on children and families, the importance of reducing health disparities,  and ways to improve access to mental health services.  This conversation was just what the doctor ordered…literally.Please subscribe, rate, and leave a review anywhere you listen to this podcast.We appreciate you all. Be Well-NOWDr. Biel Linkedin:https://www.linkedin.com/in/matthew-biel-ab97163/Georgetown University Center for Trauma and the Community:https://ctc.georgetown.edu/Youtube-Child Psychiatry: Ask Dr. Matthew Biel:https://www.youtube.com/watch?v=ifUr2Pmh7_4Dr. Biel Publications:https://www.researchgate.net/profile/Matthew-Biel* The unbelievable Shawn Bell produces the Nature of Wellness Podcast, making us sound good.** The NOW theme song was penned, performed, produced, and provided by the dynamic duo of Phil and Niall Monahan. *** This show wouldn't exist without our amazing guests and all of you who listen. Please like, subscribe, follow, and review to help us get these important messages out to more folks who can benefit from them. Thank you all.

In this CME episode, Dr. Andrew Cutler interviews Dr. Laxman Bahroo about the current landscape of tardive dyskinesia, including screening, diagnosis, and treatment. Practical strategies based on the latest data are reviewed at length, particularly for long-term management of tardive dyskinesia.  Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Consider the individual patient profile and symptoms when determining a treatment plan for patients with tardive dyskinesia Integrate latest safety, efficacy, and tolerability data of VMAT2 inhibitors into decision-making processes when considering treatment options for tardive dyskinesia Evaluate practical strategies for patient follow-up and long-term VMAT2 inhibitor treatment Evaluate and integrate recent updates and advancements regarding evidence-based treatment strategies for tardive dyskinesia Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit. Estimated Time to Complete: 1 hour Released: June 26, 2024*   Expiration: June 25, 2027 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD24-02-TD Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity Nurse: ANCC contact hours NEI designates this Enduring Material for a maximum of 1.0 ANCC contact hours Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.0 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.0 contact hour (.10 CEUs). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and is unable to report your claimed credit after this 60-day period. Physician Associate/Assistant: AAPA Category 1 CME credits NEI has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.0 AAPA Category 1 credit. Approval is valid until June 25, 2027. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, NEI is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1.0 general continuing education credits. Non-Physician Member of the Healthcare Team: Certificate of Participation NEI awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD, MPH specializing in forensics, psychosis, schizophrenia, mood disorders, anxiety, cognitive disorders — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Malvern, PA Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Laxman B. Bahroo, DO, MS, FAAN Professor and Residency Program Director, Department of Neurology, MedStar Georgetown University Hospital, Washington, DC Consultant/Advisor: AbbVie, Amneal, Ipsen, Kyowa Kirin, Merz, Neurocrine, Revance, Supernus Speakers Bureau: AbbVie, Acadia, Acorda, Amneal, Ipsen, Kyowa Kirin, Merz, Neurocrine, Supernus, Teva The remaining Planning Committee members, Content Editors, Peer Reviewer, and NEI planners/staff have no financial relationships to disclose. NEI planners and staff include Caroline O'Brien, Meghan Grady, Brielle Calleo, and Andrea Zimmerman, EdD. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement Contact Us: For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported by an unrestricted educational grant from Neurocrine Biosciences.

 | Join us for an insightful episode with Dr. Kieran Dunleavy, an internationally recognized expert in lymphoma and blood cancers. Learn about the innovative treatments and clinical trials happening at Medstar Georgetown University Hospital that are transforming patient care. Discover how accurate diagnosis and cutting-edge therapies like CAR T cells and bispecific antibodies are improving outcomes and reducing toxicity. Don't miss this opportunity to stay informed about the future of cancer treatment. Listen now! For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

In this episode, we delve into the multifaceted journey of Dr. Lucy De La Cruz MD, a trailblazer in the field of breast cancer surgery. Dr. Lucy De La Cruz MD shares her experiences from co-founding the American Medical Student Association in the Dominican Republic to becoming the youngest Latina chief of breast cancer surgery at MedStar Georgetown University Hospital. She highlights the significance of personal branding in medicine, especially in the digital age, and discusses how sharing her personal life on social media helps build trust and empathy with her patients.Key Takeaways:Building a Personal Brand: Dr. De La Cruz emphasizes that a strong personal brand helps doctors connect more deeply with patients, fostering trust and empathy. Sharing personal stories and experiences on social media can humanize doctors and make them more relatable.Authenticity and Bedside Manner: Being true to oneself and maintaining good bedside manners are crucial. Dr. De La Cruz believes that authenticity is more important than conforming to traditional expectations of how a doctor should look and act.Championing Patients: Dr. De La Cruz strives to be a champion for her patients, providing them with the support they need throughout their breast cancer journey. She underscores the importance of understanding patients' challenges outside the hospital.Breaking the Mold: As a Hispanic woman in a high-powered medical position, Dr. Lucy De La Cruz MD aims to inspire others by breaking stereotypes and setting a powerful example.Embracing Failure and Growth: Dr. De La Cruz discusses the importance of embracing failure and being comfortable in uncomfortable situations. She encourages documenting accomplishments and feedback to build confidence and overcome insecurities.Educational Reform: Dr. De La Cruz advocates for incorporating leadership and marketing education into medical school curricula to better prepare future physicians for the evolving healthcare landscape.Learn more about Dr. De La Cruz impactful work and how she is making a difference in the lives of her patients through her dedication to excellence, authenticity, and patient-centered care.

Did you know that Colorectal cancer is the second-leading cause of cancer deaths in the United States in men and women combined? March is Colorectal Cancer Awareness Month. On this episode of our DocTalk podcast, we're discussing colon cancer. Dr. Priyanka Kanth, the Director of the Gastrointestinal Cancer Prevention Program at MedStar Georgetown University Hospital talks about every aspect of colon cancer from symptoms, stages, causes, and treatment.Having accurate facts about colon and rectal cancer is very important. Whether you're reporting on a story, doing a homework assignment, or raising awareness with family, it is important to know the colon cancer signs, symptoms and risk factors.Dr. Kanth sees patients and families with high risk for gastrointestinal cancers at MedStar Georgetown University Hospital. Her area of special interest and expertise is gastrointestinal cancer, especially hereditary colon cancer and colon cancer prevention.For an interview with Dr. Priyanka Kanth, or for more information about this podcast, contact MedStar Georgetown University Hospital Manager Media Relations, Ryan.M.Miller2@Medstar.net.Learn more about Dr. Kanth.For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: How can we expand clinical education to develop the healthcare workforce we desperately need?According to our next guest, Kyle Swinsky, co-founder and CEO of AMOpportunities, it starts by equipping universities and healthcare providers with scalable infrastructure.Drawing from a passion to increase opportunities for international medical trainees, Kyle built a workforce solution that matches students to hands-on rotations while supporting host sites through technology and services.While together, we explore AMO's mission to address bottlenecks preventing schools from graduating qualified healthcare professionals and Kyle reveals how his company augments limited teaching capacity, facilitates ideal student-site relationships, and drives strategic growth into allied health fields.Join us to hear how Kyle and the AMO team is successfully expanding clinical education to develop healthcare's workforce! Let's go! Episode Highlights:AMO bridges clinical education gaps by matching students to hands-on training opportunitiesTheir platform and services augment limited teaching capacity at hospitals/clinicsStudents get experience where they want while sites gain pipeline of future workforceAMO has helped over 5,500 trainees secure rotations to advance their careersStrategic growth planned for nursing, PA, rehab therapy, and other allied health fieldsAbout our Guest: Kyle Swinsky is the co-founder and CEO of AMOpportunities, a Chicago-based company that helps international medical students and graduates secure U.S. rotations and supports hospitals and schools in managing trainees through high-quality services and software solutions.In 2013, Kyle, along with co-founder and COO Ben Bradley, launched AMOpportunities to make U.S. clinical experiences accessible to medical trainees around the world. Since 2013, AMO has tripled in size, raised $8.9 million in funding, won the President's “E” Award for Exports and PIEoneer of the Year, and helped more than 3,600 trainees rotate in the U.S. The company counts Kaplan Medical and AMSA as partners as well as institutions such as University of Miami, Chicago Medicine, MedStar Georgetown University Hospital, and Florida International University.Links Supporting This Episode:AMOpportunities Website: CLICK HEREKyle Swinsky LinkedIn page: CLICK HEREKyle Swinsky Twitter page: CLICK HERE Mike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

CardioNerds join Dr. Ethan Fraser and Dr. Austin Culver from the MedStar Georgetown University Hospital internal medicine and cardiology programs in our nation's capital. They discuss the following case involving an unusual case of rapidly progressive heart failure. Episode audio was edited by CardioNerds Academy Intern and student Dr. Pacey Wetstein. Expert commentary was provided by advanced heart failure cardiologist Dr. Richa Gupta. A 55-year-old male comes to the clinic (and eventually into the hospital) for what appears to be a straightforward decompensation of his underlying cardiac disease. However, things aren't as simple as they might appear. In this episode, we will discuss the outpatient workup for non-ischemic cardiomyopathy and discuss the clinical indicators that we as clinicians should be aware of in these sick patients. Furthermore, we will discuss the differential for NICM, the management of patients with this rare disease, and how this disease can mimic other cardiomyopathies. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media - Rapidly Progressive Heart Failure Pearls - Rapidly Progressive Heart Failure The non-ischemic cardiomyopathy workup should incorporate targeted multimodal imaging, thorough history taking, broad laboratory testing, genetic testing if suspicion exists for a hereditary cause, and a deep understanding of which populations are at higher risk for certain disease states. Key Point: Always challenge and question the etiology of an unknown cardiomyopathy – do not assume an etiology based on history/patient story alone.  Unexplained conduction disease in either a young or middle-aged individual in the setting of a known cardiomyopathy should raise suspicion for an infiltrative cardiomyopathy and set off a referral to an advanced heart failure program. Key Point: Consider early/more aggressive imaging for these patients and early electrophysiology referral for primary/secondary prevention. Giant Cell Myocarditis is a rapidly progressive cardiomyopathy characterized by high mortality (70% in the first year), conduction disease, and classically presents in young/middle-aged men. Key Point: If you have a younger male with rapidly progressive cardiomyopathy (anywhere as quickly as 1-2 months, weeks in some cases) and conduction disease, consider early endomyocardial biopsy, even before other advanced imaging modalities. The Diagnosis of Giant Cell Myocarditis is time-sensitive - early identification and treatment are essential to survival. Key Point: The median timeframe from the time the disease is diagnosed to the time of death is approximately 6 months. 90% of patients are either deceased by the end of 1 year or have received a heart transplant. The treatment of Giant Cell Myocarditis is still governed largely by expert opinion, but the key components include high-dose steroids and cyclosporine, largely as a bridge to transplantation or advanced heart failure therapies. Key Point: Multi-disciplinary care is essential in delivering excellent care in the diagnostic/pre-transplant period, including involvement by cardiology, cardiac surgery, radiology, critical care, allergy/immunology, case management, advanced heart failure, and shock teams if necessary. There remains significant clinical overlap between Giant Cell Myocarditis and sarcoidosis, making managing equivocal cases challenging. Key Point: Consider early FDG-PET imaging in equivocal cases, as management during the pre-transplant period and evaluation of transplant candidacy can vary drastically between the two. Show Notes - Rapidly Progressive Heart Failure 1.

You've just had your appointment with your neurologist or MS Specialist and you're on your way home, feeling like you weren't heard. Maybe there wasn't sufficient time. Or it might feel like your opinion simply isn't valued. Your frustration could even be the result of language issues and cultural barriers that make communication difficult. Whatever the reason, it doesn't have to be this way. Dr. Luis Manrique-Trujillo joins me this week to share tips and strategies that will improve the quality of communication between you and every member of your MS care team. Dr. Manrique-Trujillo is a neurologist specializing in neuroimmunology and multiple sclerosis at MedStar Georgetown University Hospital in Washington, D.C. We're also sharing some fascinating research that traces the gene variants that increase someone's risk of developing MS all the way back to the Bronze Age. We'll tell you about a small study that may explain how the Epstein-Barr Virus triggers MS. We'll tell you about a class-action lawsuit that accuses Pharmacy Benefit Managers of illegal collusion and price-fixing. (And we'll explain why this lawsuit could be a huge step toward lowering the cost of your prescription medications) And we're sharing our plans for RealTalk MS in 2024. We have a lot to talk about! Are you ready for RealTalk MS??! My New Year's Resolutions for RealTalk MS  :22 This Week: Improving communication between you and your neurologist  4:59 STUDY: Ancient DNA reveals how MS risk genes arose and spread across Europe  5:59 STUDY: EBV-specific T-cells may play a key role in developing MS  9:36 An important class-action lawsuit has been filed against Pharmacy Benefit Mangers  11:18 Dr. Luis Manrique-Trujillo shares strategies for improving communication between you and your neurologist   15:41 Share this episode  34:19 Have you downloaded the free RealTalk MS app?  34:40 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/333 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com STUDY: Elevated Genetic Risk for Multiple Sclerosis Emerged in Steppe Pastoralist Populations https://www.nature.com/articles/s41586-023-06618-z STUDY: Expanded T Lymphocytes in the Cerebrospinal Fluid of Multiple Sclerosis Patients are Specific for Epstein-Barr-Virus-Infected B Cells https://pnas.org/doi/abs/10.1073/pnas.2315857121 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 333 Guest: Dr. Luis Manrique-Trujillo Privacy Policy

Episode 004 | Dr. Adam Swigost on his journey to building a solo direct care practice in his home state of North Dakota.Dr. Adam Swigost is a board-certified dermatologist and the founder of Dapper Dermatology, North Dakota's first and only entirely virtual dermatology clinic. As a North Dakota native, Dr. Swigost wanted to create a clinic that would help to expand access to dermatology services in a state where wait times can exceed several months. Additionally, Dapper Dermatology is a direct patient care clinic that is working to lower costs, increase financial transparency, and improve access to dermatology services. Dr. Swigost is an advocate for physician autonomy and reinvigorating the patient-physician relationship. Dr. Swigost completed his undergraduate degrees and medical training at the University of North Dakota. He completed his internship through the University of Central Florida in Ocala, FL, and his dermatology residency at Medstar Georgetown University Hospital and Washington Hospital Center in Washington, DC. He is a member of the American Academy of Dermatology, the American Society for Dermatologic Surgery, and the Gay and Lesbian Dermatology Association.Thank you to my partners at RegimenPro for sponsoring the Treat Yo' Self Skincare Giveaway! Learn more here.

Conversation w/ Eric Anderson, MD, Director, Interventional Pulmonology, MedStar Georgetown University Hospital and Associate Professor Georgetown University, about lung cancer prevalence, risk factors, diagnosis, treatment and prevention.

Medical oncologist Dr. Joshua Reuss, an expert in lung cancer, mesothelioma and thymoma, and pulmonologist Dr. Rebecca Krochmal, an expert in benign and malignant airway and pleural disease, both with MedStar Georgetown  University Hospital in Washington, D.C., address questions related to finding and treating lung cancer. For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Drs. Shaalan Beg and Priyanka Kanth discuss the readiness, logistics, and barriers to implementing universal germline multigene panel testing for colorectal cancer (CRC) following new guidelines from the National Comprehensive Cancer Network that recommend genomic testing for all individuals with CRC younger than age 50. The experts also address other areas of unmet needs as new data emerge on moderate-risk genes and their association with CRC. TRANSCRIPT Dr. Shaalan Beg: Hello, and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg, your guest host of the podcast today. I'm the vice president of oncology at Science 37 and an adjunct associate professor at UT Southwestern Medical Center in Dallas. Last year, the National Comprehensive Cancer Network, or NCCN, updated its guidelines on colorectal cancer (CRC), recommending that all patients with colorectal cancer who receive a diagnosis before the age of 50 have multigene panel testing and that multigene testing should also be considered for patients 50 years of age and older with colorectal cancer, regardless of a personal or family history or other criteria. This represents a huge paradigm shift in the screening and care of patients with inherited cancers. And today, I'm joined by Dr. Priyanka Kanth, an associate professor of medicine and the director of the GI Cancer Prevention Program at MedStar Georgetown University Hospital in Washington, DC, to discuss new research that explores the readiness, logistics, and barriers associated with the implementation of universal germline testing in clinical practice.  You'll find our full disclosures in the transcript of this episode, and disclosures of all guests on the podcast are available at asco.org/DNpod. Dr. Kanth, it's great to have you on the podcast today. Dr. Priyanka Kanth: Thank you, Dr. Beg. It's wonderful to be here today and discuss this very exciting topic. Dr. Shaalan Beg: As a gastroenterologist who sees patients and families with a high risk for GI cancer, including medically underserved populations, can you comment on the significance of the expanded NCCN guidelines for colorectal cancer? Dr. Priyanka Kanth: Yes, absolutely. So this is, I would say, a big change from NCCN recommending pretty much every colorectal cancer patient can undergo multigene panel testing or universal. So everyone who's younger than age 50 and has colon cancer should get multigene panel testing. But we are also expanding it to pretty much anyone who may have colorectal cancer, and we can offer multigene panel testing. So, we are broadening the pool of patients who can get tested, and this will bring in more patients from very different demographics. So I think it will expand to every arena of patients with different insurance profiles, underserved, and, as more insurance companies and Medicare/Medicaid picks up, I think this will help a lot more patients in not only following on their genetic testing, but also their family members.  Dr. Shaalan Beg: Medical oncologists are very familiar with the challenges of implementing somatic molecular testing for people who have cancer. I can only imagine that implementing universal germline testing also has significant logistical challenges and barriers. You recently published a study in JCO Precision Oncology along with your colleagues and captured some interesting perspectives from clinicians on their practice of implementing universal genomic testing for colorectal cancer. Can you tell us more about this? Dr. Priyanka Kanth: Absolutely. So I would first like to thank the lead authors and senior authors of this study. They are Linda Rodgers-Fouche and Sanjeevani Arora and Rachel Hodan, who literally wrote the study and created and did all the legwork. And as you know how hard it is to do these big survey studies, so really thank them.  The study is a cross-sectional survey of the members of this Community Collaborative Group of America, IGC, which I would say comprises a lot of genetic counselors, gastroenterologists, oncologists, and colorectal surgeons who take care of these patients. So these are highly specialized groups that work in the field of GI genetics. Roughly 300 plus members were sent the survey to get their take on how they think [multigene panel testing] can be implemented for all colorectal cancer patients.   So to give you a synopsis of the study, the majority of members who participated, 70% or more, they supported this universal germline testing for colorectal cancer patients. But interestingly, more than 50% also thought that it will require a change in their practice or how this will be delivered. So that's the major takeaway, I would say. We are all supportive but how to really deliver to the patient would be the biggest challenge or barrier for us in the future.  Dr. Shaalan Beg: So, your study reported concerns on knowledge among non-genetics providers. I would assume that includes a lot of clinicians who are the first people to be in contact with potential patients who would require testing. How can the field mitigate this problem? And what are some alternate delivery service models for increasing awareness and making the process of ordering and following up on the results more efficient for practices? Dr. Priyanka Kanth: We all know the biggest barrier I would say is resources like who's going to deliver the added pool of patients that get genetic testing. So most of the current scenario, they're all seen by genetic counselors, but we have a limited number of genetic counselors and they cannot truly deal with this big influx. So how to educate non-genetic providers would be the biggest barrier. But also implementing in the system itself, like can we do pretest counseling as the first contact with the patient to deliver to discuss like you should undergo genetic testing. So that contact, can that be done with a non-genetic provider or even by other modes like telemedicine? Or can we do something like an online chat box or something which could just not only go over all the types of testing but opens the door for the patient to ask questions. So if there are alternate modes of delivery where the pretest is taken care of, that would be one big change required.   The other part is like when the test is done, who returns the results? So where does it go and who explains the results? So at that point, we surely need more genetic and even non-genetic providers if they are comfortable. So how to educate them would be the biggest barrier. At that point, I think, we are still figuring out the biggest change is in the system and requiring a take from all the stakeholders who are part of taking care of these patients. So not only genetic counselors, but oncologists, gastroenterologists, pathologists who are taking care of this patient to be on board and have a really clear-cut flow of how these are delivered, how these results are returned, and how they are explained to family members. Dr. Shaalan Beg: The workflows and the resources that you have in a high-risk GI clinic at a center like Georgetown's, I think it's safe to say, are much more than what typical resources a practicing provider will have in the clinic. How do you envision clinics resourcing for this type of test either through training or retraining their existing staff or by adding additional resources?  Dr. Shaalan Beg: At the community setting, it is really hard to educate essentially everyone as well. So, I feel like taking the load off the genetic counselor at the pretest level is the biggest implementation or change that can be done. And if we can remove that because not every patient is going to be positive for the gene mutation either; it does filter many patients who eventually will need returns. So at that place, how do you implement and where do you implement is the key and it is so system-based that I cannot even pinpoint. But I agree, bigger academic centers have better advantages and a knowledge base as compared to smaller community cancer centers or practices. Dr. Priyanka Kanth: Yeah, and I noticed that many of the respondents in your survey agreed with offering multigene panels, but there was variability by profession, and I was wondering if that resonated with you and that was an expected finding or not. Dr. Priyanka Kanth: Yes, and it was more so in terms of standardized multigene panel versus customized panel. So, this is fairly understandable because the genetic counselor is so well versed in offering which genes should be tested based on family history, but a non-genetic provider may not be fully equipped with the knowledge. So for example, myself, I do GI genetics, but if I have a patient with a lot of breast cancer in the family, I do defer them to a high-risk breast team. So there are nuances, too. The major difference here was also in standardized multigene panel, most of the gastroenterologists, oncologists were all for it compared to customized, which were more heavily leaned by the genetic counselor based on family history. And I can see why it's different because standardized, I would say, is much easier to implement and compared to customizing, which is based on family history or other cancer history and family. That's the major difference in the study. It comes down to education and experience and the follow-up based on what comes back from it.   Dr. Shaalan Beg: You've highlighted many factors, both from the pre-test, sort of preparing and selecting the right individuals, to ordering the right test based on the participant's risk factor profile and then optimal ways of following up on the results of these genomic tests. What are other areas of unmet needs when it comes to genomic testing for colorectal cancer? Dr. Priyanka Kanth: We know a lot about high-risk genes that are associated with colorectal cancer. We still are finding and learning about many genes, many moderate-risk genes, and their association with colorectal cancer. We don't have enough data or long-term cohort data to understand how they truly affect their lifetime risk for colorectal cancer and how do we truly surveil these patients. So that's one of the big barriers. Genetics still cannot explain all colorectal cancers. So as we get more data, we may discover more things and more genes that may be associated. But understanding these moderate-risk genes and their association with colorectal cancer would be, I think, one of the key areas to be looked into in the future. Dr. Shaalan Beg: And I would imagine as new biomarkers are identified, there will need to be a strategy to retest people who may have had genomic testing in the past. Dr. Priyanka Kanth: Absolutely. We are already encountering that in a practice. I have patients who have been tested maybe 10 years ago and just had Lynch mutation tested and were negative for that or so, and now we have so many other genes which are associated and also to understand family history changes. So, as family history changes, there might be clues to say that, “Okay, we should expand the panel or we should add these patients.” So it is a very dynamic situation. There could be a scenario in which we have a lot of patients who may need to be retested based on their current situation or even based on changing family history and the availability of genetic information. So, when I see a patient, I also tell them if we don't find anything or we are not doing anything major, we say, “Let's regroup in 3 to 5 years, let's see where we are,” or even with the risk mutation for some of the moderate-risk genes, we may change in a few years. So, revisiting that with these patients is highly useful. Dr. Shaalan Beg: So, is it safe to say that as of 2023, if we're seeing people in our clinic who have not had testing in the last 3 to 5 years, that they should have a discussion for repeat testing today? Dr. Priyanka Kanth: Yes, in terms of certain, I would say, newer polyposis genes in the GI world that have been included, some other moderate gene mutation which we have a little bit more sense of now and it has not been tested, I think that can be expanded. Five years is a safe bet. Last 2 to 3 years, maybe not so much, but you can revisit this. Also, some patients were tested for a smaller gene panel. So not 2 genes, but maybe 10 genes were included. That would probably still stand true. They may not need 70 gene panels, so it's still good to review that in the current scenario, and every few years, every 5 years, I would say.   Dr. Shaalan Beg: Whenever I think about any type of new test that has logistical challenges, has costs associated with it, and has operational demands of the clinic, I think about its disparate effect across different populations based on race, ethnicity, geography, demographics. Can you talk a little bit about how these guideline changes, what type of impact they may have, positive or not, for comprehensive genomic testing for colorectal cancer across different populations?  Dr. Priyanka Kanth: Yes, I think this is more positive than negative. This will include more patients and include more family members who were not being included, who were being missed. As we know that one of the reasons to do this multigene panel testing was the criteria, the family history criteria or the risk prediction models are not perfect. And the recent studies have shown that not every family member, every patient, is going to fit in these criteria. So we are getting more and more data in recent years that I think the much better, long-term option is to do a multi-chain panel and find it because we are missing patients. So it will increase the pool [of patients to be tested], and that will surely increase patients from all demographics. And as we do it more, there will be more buy-in from the payers and hopefully, this will decrease disparity. The problem, I think the negative part is how do we deliver it to everyone? If it is there but we are not able to deliver and that there is disparity on who gets the test and who does not, then that will create another disparity in a sense that it's there and we could have used it, but it's not being delivered. So the pros are we can include everyone, but how to include everyone is the big question. Dr. Shaalan Beg: So, Dr. Kanth, there are indeed challenges ahead in our pursuit for universal germline testing for colorectal cancer. I'd like to thank you for sharing your valuable insights with us today on the ASCO Daily News Podcast.   Dr. Priyanka Kanth: Thank you very much for having me here. It was great to talk to you, Dr. Beg. Dr. Shaalan Beg: And thank you to our listeners for your time today. Finally, if you value the insights that you hear on the podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer:  The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experiences, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:   Dr. Shaalan Beg @ShaalanBeg   Dr. Priyanka Kanth @priyanka_kanth   Follow ASCO on social media: @ASCO on Twitter ASCO on Facebook  ASCO on LinkedIn    Disclosures:   Dr. Shaalan Beg: Employment: Science 37 Consulting or Advisory Role: Ipsen, Array BioPharma, AstraZeneca/MedImmune, Cancer Commons, Legend Biotech, Foundation Medicine Research Funding (Inst.): Bristol-Myers Squibb, AstraZeneca/MedImmune, Merck Serono, Five Prime Therapeutics, MedImmune, Genentech, Immunesensor, Tolero Pharmaceuticals Dr. Priyanka Kanth:  Patents, Royalties, Other Intellectual Property: Methods and Compositions for Predicting a Colon Cancer Subtype

In this episode, PACEs Connection partners with the National Training and Technical Assistance Center for Child, Youth, and Family Mental Health (NTTAC) to discuss the importance of healing-centered youth engagement. Our hosts, Ingrid Cockhren & Mathew Portell, will interview Joshua Smith. Smith is a juvenile justice advocate and peer support expert. Join us for a rich discussion highlighting how healing-centered approaches are the next level of trauma-informed care. NTTAC provides states, tribes, and communities with training and technical assistance (TTA) on children's behavioral health, with a focus on systems of care. SAMHSA has awarded the Center for Applied Research Solutions (CARS) to implement the National Training and Technical Assistance Center for Child, Youth, and Family Mental Health (NTTAC). CARS leads a partnership that includes Georgetown University Center for Child and Human Development, MedStar Georgetown University Hospital, Texas Institute for Excellence in Mental Health, Change Matrix, American Academy of Pediatrics, FREDLA (Family-Run Executive Director Leadership Association), and Youth MOVE National. NTTAC is a SAMHSA-funded initiative to increase access to, effectiveness of, and dissemination of evidence-based mental health services for young people (birth to age 21) and their families, including young people experiencing serious mental illness or serious emotional disturbance (SMI/SED). NTTAC supports Children's Mental Health Initiative (CMHI) grantees and provides an array of trainings, technical assistance, and resources to providers, organizations, and agencies from across the system of care.

In this episode, PACEs Connection partners with the National Training and Technical Assistance Center for Child, Youth, and Family Mental Health (NTTAC) to discuss the importance of healing-centered youth engagement. Our hosts, Ingrid Cockhren & Mathew Portell, will interview Joshua Smith. Smith is a juvenile justice advocate and peer support expert. Join us for a rich discussion highlighting how healing-centered approaches are the next level of trauma-informed care. NTTAC provides states, tribes, and communities with training and technical assistance (TTA) on children's behavioral health, with a focus on systems of care. SAMHSA has awarded the Center for Applied Research Solutions (CARS) to implement the National Training and Technical Assistance Center for Child, Youth, and Family Mental Health (NTTAC). CARS leads a partnership that includes Georgetown University Center for Child and Human Development, MedStar Georgetown University Hospital, Texas Institute for Excellence in Mental Health, Change Matrix, American Academy of Pediatrics, FREDLA (Family-Run Executive Director Leadership Association), and Youth MOVE National. NTTAC is a SAMHSA-funded initiative to increase access to, effectiveness of, and dissemination of evidence-based mental health services for young people (birth to age 21) and their families, including young people experiencing serious mental illness or serious emotional disturbance (SMI/SED). NTTAC supports Children's Mental Health Initiative (CMHI) grantees and provides an array of trainings, technical assistance, and resources to providers, organizations, and agencies from across the system of care.

In this episode, PACEs Connection partners with the National Training and Technical Assistance Center for Child, Youth, and Family Mental Health (NTTAC) to discuss the importance of healing-centered youth engagement. Our hosts, Ingrid Cockhren & Mathew Portell, will interview Joshua Smith. Smith is a juvenile justice advocate and peer support expert. Join us for a rich discussion highlighting how healing-centered approaches are the next level of trauma-informed care. NTTAC provides states, tribes, and communities with training and technical assistance (TTA) on children's behavioral health, with a focus on systems of care. SAMHSA has awarded the Center for Applied Research Solutions (CARS) to implement the National Training and Technical Assistance Center for Child, Youth, and Family Mental Health (NTTAC). CARS leads a partnership that includes Georgetown University Center for Child and Human Development, MedStar Georgetown University Hospital, Texas Institute for Excellence in Mental Health, Change Matrix, American Academy of Pediatrics, FREDLA (Family-Run Executive Director Leadership Association), and Youth MOVE National. NTTAC is a SAMHSA-funded initiative to increase access to, effectiveness of, and dissemination of evidence-based mental health services for young people (birth to age 21) and their families, including young people experiencing serious mental illness or serious emotional disturbance (SMI/SED). NTTAC supports Children's Mental Health Initiative (CMHI) grantees and provides an array of trainings, technical assistance, and resources to providers, organizations, and agencies from across the system of care.

Plastic surgery is a profession that seems to be almost inextricably linked with certain ideas about physical beauty in popular culture. Yet, l have often wondered whether working in the field might not give plastic surgeons a more nuanced understanding of beauty than we tend to give them credit for.In this episode of This is Beauty Podcast, I talk to Plastic Surgeon and Researcher Dr. Michael Reilly, a double-board certified facial plastic and reconstructive surgeon at MedStar Georgetown University Hospital in Washington, DC, about the subject of beauty and the role it plays in his profession and his practices, both as a cosmetic and reconstructive surgeon. How does the concept of beauty inform his work and how has his work influenced, or been influenced by, his personal philosophy of beauty?While I have always had lots of questions on the subject, plastic surgery is a topic that I've always skirted on the show until now — not because it doesn't have a place here, but because I really wanted to avoid the kind of skin-deep only conversations that can erupt when people mention beauty and plastic surgery in the same breath. In Michael, I found not only an expert on the subject of cosmetic and reconstructive surgery, but someone who has clearly given the concept of beauty and its relationship to his work serious thought.In this conversation, we discuss Michael's work with both his cosmetic and reconstructive surgery patients and how beauty takes on different meanings depending upon the objectives of the procedure and more!Enjoy!When perfection matters Social media's influence on the field of plastic surgeryHow mental health and self-esteem influence patient outcomesDr. DeSilva on the Golden Ratio and the most world's most beautiful womenDefinitions of beauty Bell's Palsy and Facial Paralysis Who benefits most from plastic surgeryWhy men seek plastic surgeryStandards of physical beauty: men vs. womenAge as a factor in proceduresWhy people elect plastic surgeryMentioned in this episode:MedStar Georgetown University Hospital The Most Beautiful Women in the World - Dr. Julian DeSilvaBell's Palsy and Mental HealthPsychology Today Blog: Dissecting Plastic SurgerySocial Media Drives Interest in Plastic Surgery ProceduresPlastic Surgery Can Make You More LikeableAbout Today's Guest:Doctor Michael Reilly is a Professor of Otolaryngology--Head & Neck Surgery at Georgetown University Medical Center and a double-board certified facial plastic and reconstructive surgeon at MedStar Georgetown University Hospital in Washington, D.C. His areas of expertise include both facial cosmetic surgery, including the full spectrum of minimally invasive treatments, and facial reconstructive surgery, with particular interests in the areas of nerve paralysis and microvascular reconstructive and melanoma...

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with a variety of specialists in neurology who presented research and gave talks at 4 recent major medical meetings—the Consortium of MS Centers Annual Meeting, the Annual Joint SLEEP Meeting, the Advanced Therapeutics in Movement and Related Disorders Congress, and the American Headache Society's Annual Scientific Meeting. Those included in this week's episode, in order of appearance, are: Amit Bar-Or, MD, FRCPC, FAAN, FANA, the Melissa and Paul Anderson President's Distinguished Professor at the Perelman School of Medicine of the University of Pennsylvania. Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath, a professor of neurology at Barts and The London School of Medicine and Dentistry. Dayna Johnson, PhD, MPH, MSW, MS, a sleep epidemiologist and assistant professor at the Rollins School of Public Health at Emory University. John Winkelman, MD, PhD, the chief of the Sleep Disorders Clinical Research Program at Massachusetts General Hospital. Laxman Bahroo, DO, a professor of neurology and the residency program director at MedStar Georgetown University Hospital. Ling Wan-Albert, OTD, OTR/L, an assistant professor of occupational therapy at the New York Institute of Technology. Sara Pavitt, MD, the chief of headache at UT Austin Dell Children's Hospital. Ali Ezzati, MD, the director of the Neuroinformatics Program at the University of California, Irvine. Want more from all of NeurologyLive's coverage of these medical meetings—including dozens more interviews with expert clinicians—click the links below: Consortium of Multiple Sclerosis Centers Annual Meeting SLEEP, the Joint American Academy of Sleep Medicine and the Sleep Research Society Meeting Advanced Therapeutics in Movement and Related Disorders Congress American Headache Society Annual Scientific Meeting Episode Breakdown: 1:15 – Bar-Or on the potential of BTK inhibition in multiple sclerosis at CMSC 2023 4:40 – Giovannoni on the understanding of MS as a smoldering disease at CMSC 2023 10:30 – Johnson on multilevel efforts to address modifiable factors of sleep health at SLEEP 2023 13:05 – Winkelman on moving away from dopamine agonists as first-line treatments for restless legs syndrome at SLEEP 2023 15:30 – Bahroo on the role of botulinumtoxins in Parkinson disease care at ATMRD 2023 19:00 – Wan-Albert on the impact of social isolation on cognition at ATMRD 2023 22:10 – Pavitt on the universal knowledge about pediatric headache for neurologists and nonspecialists at AHS 2023 24:05 – Ezzati on the use of machine learning models to improve treatment optimization in heterogenous migraine at AHS 2023 This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com. Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

We have a very special guest with us, Dr. Robert Shin. He also goes by Bob. On today's episode, we talk about racial and ethnic disparities in multiple sclerosis. Dr. Shin has a special interest in health disparities in multiple sclerosis, as well as visual problems associated with MS and other demyelinating disorders Robert K Shin, MD, FANA, FAAN, is a graduate of Yale University and received his medical degree from the University of Pennsylvania School of Medicine. He completed a neurology residency and fellowships in neuro-ophthalmology and multiple sclerosis at the Hospital of the University of Pennsylvania. Dr. Shin is currently Professor of Neurology at MedStar Georgetown University Hospital and Director of the Georgetown Multiple Sclerosis and Neuroimmunology Center. Dr. Shin has a special interest in health disparities in multiple sclerosis (MS) as well as visual problems associated with MS and other demyelinating disorders, including neuromyelitis optica spectrum disorder (NMOSD). Links mentioned in this episode:⭑https://www.naamsr.org/ ⭑https://clinicaltrials.gov/ ⭑https://neurology.georgetown.edu/mscenter/ Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: hello@doctorgretchenhawley.com Website: www.MSingLink.com Social: ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink

Dean's Chat host, Dr. Jeffrey Jensen, is joined by Dr. John Steinberg. A third-generation podiatrist, Dr. Steinberg has spent the past 11 years as the Residency Director at Medstar Health Podiatric Surgery Residency Program. He is a Past President of the American College of Foot and Ankle Surgeons. A graduate of Barry University School of Podiatric Medicine, he is currently on the Barry University Board of Trustees. Tune in for discussions on residency training, leadership qualities, fellowship training, and the future of Podiatric Medicine. In this episode of Dean's Chat, Dr. Jeffrey Jensen welcomes Dr. John Steinberg, a professor and full-time faculty member in the Department of Plastic and Reconstructive Surgery at Georgetown University School of Medicine. Dr. Steinberg is also the co-founder of the Center for Wound Healing at MedStar Georgetown University Hospital. Dr. Jensen and Dr. Steinberg discuss Dr. Steinberg's impressive career and his role as a leader in the field of podiatric medicine. Dr. Jensen and Dr. Steinberg delve into the significance of mentorship in professional development. They stress that mentorship is not a happenstance occurrence, but rather something that individuals must actively pursue and request. Dr. Steinberg shares valuable advice given to his residents and students, emphasizing that mentorship is purposeful and that individuals should not hesitate to approach someone who inspires them and express their desire to learn from them.  Dr. Steinberg also highlights that mentors are eager to guide and support, but if not approached, they may not realize that someone is seeking their mentorship. He encourages individuals to actively seek out mentorship and overcome any fear of asking for guidance and support. Dr. Steinberg underscores the impact of mentorship in his own career, noting that his mentors have not only shaped his present self but have also opened doors for his professional growth.  In this episode, Dr. Jensen and Dr. Steinberg emphasize the importance of seeking feedback for personal and professional growth. They assure listeners that they are always willing to provide feedback and make time for it, highlighting the willingness of mentors to offer guidance. They encourage listeners not to shy away from asking for feedback, as many people are willing to provide it but may not do so unless prompted. Asking for feedback is crucial because without doing so, individuals may never receive the valuable insights needed for improvement. Dr. Jensen and Dr. Steinberg encourage listeners to be proactive in their education and actively seek feedback to make the most of each day.    https://aacpm.org/ https://www.medstarhealth.org/education/residency-programs/podiatric-surgery-dc Dean's Chat Website  Dean's Chat Episodes  Dean's Chat Blog Why Podiatric Medicine?  Become a Podiatric Physician

 Dr. Virginia D. Steen is a Professor of Medicine and Chief of the Division of  Rheumatology at Medstar Georgetown University Hospital. Today, our topic is the lungs. An issue that affects many Scleroderma warriors. We discuss in detail pulmonary arterial hypertension and pulmonary fibrosis. By the time we are done talking, you will be well better informed on this topic!

In this episode of the PRS Global Open Keynotes Podcast, Dr. Karen Evans and Dr. Christopher Attinger discuss the safety of continuing antiplatelet and anticoagulant medications in patients undergoing split skin graft procedures. This episode discusses the following PRS Global Open article: Neither Antiplatelet nor Anticoagulant Therapy Increases Graft Failure after Split-thickness Skin Grafting by Elliot T. Walters, Kevin G. Kim, Paige K. Dekker, Gregory P. Stimac, Shyamin Mehra, Tammer Elmarsafi, John S. Steinberg, Christopher E. Attinger, Paul J. Kim and Karen K. Evans. Read the articles for free on PRSGlobalOpen.com:https://bit.ly/AntiplateletnorAnticoagulant Drs. Evans and Attinger are both Professors in the Department of Plastic and Reconstructive Surgery at Medstar Georgetown University Hospital in Washington, DC. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Surgery at the University of Sydney in Australia. #PRSGlobalOpen #KeynotesPodcast #PlasticSurgery

Comprehensive, relevant and insightful conversations about health and medicine happen here… on MedStar Health Doc Talk. CyberKnife®, also known as stereotactic body radiation therapy (SBRT), is non-surgical, highly precise, targeted radiation, with minimal damage to surrounding healthy tissue. Unlike conventional prostate radiation therapy that can take up to 40 sessions, CyberKnife treats prostate cancer in only five treatments. This treatment is extremely accurate and painless. This treatment causes minimal side effects and requires virtually no recovery time. Listen to Dr. Sean Collins, radiation oncologist and director, CyberKnife Prostate Program, MedStar Georgetown University Hospital, discuss the benefits of using CyberKnife to treat prostate cancer, how it compares to traditional radiation treatment, and why patients should choose MedStar Georgetown for their CyberKnife prostate cancer treatment. For interviews with Dr. Collins, or for more information about this podcast, contact Matt Holzapfel, matthew.m.holzapfel@medstar.net.Learn more about Dr. Collins here: MedStarHealth.org/CollinsLearn more about: CyberKnife at MedStar Georgetown University HospitalFor more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

In this week's edition of Tranquility du Jour, I chat with Lauren Brownstein about her new book Be Well, Do Good: Self-Care and Renewal for Nonprofit Professionals and Other Do-Gooders. Learn how to incorporate self-care into the work you do, how gratitude has had a big impact on Lauren, and ways to let your light shine at work and beyond. Direct download: Tranquility du Jour #601: Be Well, Do Good Subscribe in your favorite podcast app such as Spotify, Apple Podcast, Amazon. Visit kimberlywilson.com/podcast for more. New to Tranquility du Jour? Learn more here. Upcoming Events April 1: TDJ Style Spring Virtual Event April 15: Seasonal Retreat Immersion Video Interview https://youtu.be/92SvCAdYrTM Our Guest Lauren Brownstein Lauren Brownstein has been working in philanthropy for 30 years as a fundraiser, educator, program manager, and administrator. She helps non-profit organizations, philanthropists, and grant makers achieve their goals through PITCH, LLC, her fundraising and philanthropy consulting practice. She is the author of Be Well, Do Good: Self-Care and Renewal for Nonprofit Professionals and Other Do-Gooders, a Barnes & Noble Bestseller. She has raised millions of dollars for workforce development programs, museums, student support organizations, women's causes, community centers, international groups, associations, and more. Her areas of expertise include: foundation relations, development planning, and staff and board training. Lauren is known as a “master grant writer” and is adept at clean, concise, compelling writing that helps her clients' work leap off the page. She delivers learning experiences and trainings that are interactive, results-oriented, meaningful, and fun, drawing on her background in experiential education and the arts. Lauren has led numerous workshops to help individual donors define their philanthropic goals and create charitable giving plans that reflect their values, passions, and priorities. She also has managed the grant making process for a small nonprofit and is a Certified Consultant with 21/64, an organization devoted to advising family philanthropies and intergenerational giving cohorts. As a reflection of her commitment to philanthropy and volunteerism, Lauren has served on the boards of several nonprofits and has volunteered extensively in the community, including eight years as a weekly volunteer at the Lombardi Comprehensive Cancer Center at MedStar Georgetown University Hospital. She was a certified foster parent before adopting a child from the foster care system. Whether teaching yoga, journaling, meditating, crafting, traveling internationally, laughing with friends, or lacing up her sneakers to take a long walk, Lauren is committed to cultivating calm and finding inspiration. She earned a Masters in Teaching in Museum Education from the George Washington University (where she has served as a lecturer on fundraising) and a Bachelors with High Distinction from the University of Virginia. Find Our Guest Book LinkedIn Website Mentioned in the Show 600th Podcast Soiree Balletcore Sneak Peek Let's Connect Receive inbox love through Love Notes: invites, inspiration, and more. Browse my 6 Books and planner. Follow along on Instagram and YouTube. Shop seasonless, vegan, locally-made, eco-friendly fashion: TDJ by Kimberly. Share a review on Apple Podcasts, Amazon, or Goodreads and you may hear it shared on the show.

Comprehensive, relevant and insightful conversations about health and medicine happen here… on MedStar Health Doc Talk. Veterans across the country who are in need of a life-saving liver or kidney transplant now can receive these procedures at one of the top transplant centers in the nation, MedStar Georgetown Transplant Institute, thanks to the recent inclusion of the MedStar Health program in the Veterans Health Administration network. The newly established relationship expands veterans' access to a top ten transplant center in the nation allowing them to receive lifesaving care at one of the most experienced transplant programs in the country. This new DC VA Medical Center partnership with MedStar Georgetown Transplant Institute establishes MGTI as one of only a handful of VHA transplant centers in the country to offer both liver and kidney transplant. Listen to Dr. Rohit Satoskar, Director, Medical Services, MedStar Georgetown Transplant Institute, and Dr. Atoosa Rabiee, Chief, Transplant Services, Washington D.C. VA Medical Center, discuss this new partnership and how it benefits military veterans in need of liver or kidney transplants across the country. For interviews with Dr. Satoskar, or for more information about this podcast, contact Matt Holzapfel, matthew.m.holzapfel@medstar.net.Learn more about Dr. Satoskar here: MedStarHealth.org/SatoskarLearn more about: The Veterans Health Administration adding MedStar Georgetown Transplant Institute to its National Solid Organ Transplant NetworkFor more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

In this CLASSIC Aging Matters episode, host Cheryl Beversdorf talks with Priyanka Kanth, MD, Gastroenterologist and Director, Gastrointestinal Cancer Prevention Program, MedStar Georgetown University Hospital, about signs and symptoms, risk factors, diagnostic screening, and treatment for colorectal cancer, and lifestyle changes to reduce risk

Comprehensive, relevant and insightful conversations about health and medicine happen here… on MedStar Health Doc Talk.What are some of the most recent advancements in targeted treatments for patients with GI cancers? Have there been any recent advancements in how we use immunotherapy to treat GI cancers? And how do patients with localized GI cancers like rectal and pancreatic cancer benefit from having access to a multidisciplinary care team? Dr. Ben Weinberg is gastrointestinal medical oncologist at MedStar Georgetown University Hospital who is focused on developing new therapies for colorectal and pancreatic cancers by translating research from animal models into early phase clinical trials in humans. He also studies young patients with colorectal cancer and their microbiome in order to understand the dramatic rise in incidence of left-sided colon and rectal cancers in this population. For interviews with Dr. Weinberg, or for more information about this podcast, contact Matt Holzapfel, matthew.m.holzapfel@medstar.net.Learn more about Dr. Weinberg here: MedStarHealth.org/WeinbergLearn more about: GI cancer treatment at MedStar Georgetown University HospitalFor more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Emily Parks is a chronically ill young professional based out of San Francisco working in behavioral health and patient advocacy. Having been diagnosed with short bowel syndrome in infancy and unable to absorb nutrition orally, she was dependent on Parenteral Nutrition until receiving an isolated small bowel transplant from MedStar Georgetown University Hospital. Combining her expertise in behavioral health with her lived experience of navigating multiple tertiary hospitals firsthand has led her down the path of studying the impact of medical trauma and medical PTSD on patients and its influence on treatment outcomes. Emily founded the organization POP!, where she hosts patient lead discussion groups on all things medical PTSD related in an effort to learn what providers need to know about the mental health side of the patient experience.

This activity expires on MONDAY, DECEMBER 5! In this podcast episode from i3 Health, expert faculty provide insight on new data and emerging strategies for patients with migraine headaches including prevention, treatment, and strategies for management related to adverse events and supportive care. Presented by Jessica Ailani, MD, Director, MedStar Georgetown Headache Center, MedStar Georgetown University Hospital, and Calli Cook, DNP, APRN, FNP-C, FAANP, Clinical Assistant Professor, Nell Hodgson Woodruff School of Nursing, Emory University. Listen now! Click here to claim CME/NCPD/CPE credit: https://i3health.com/podcast-migraine

This week we're replaying a classic episode where your hosts Steve Lowry and Yvonne Godfrey interview Patrick Malone of Patrick Malone & Associates, P.C. (https://www.patrickmalonelaw.com/).   Remember to rate and review GTP in iTunes: Click Here to Rate and Review   Episode Details: Acclaimed Washington, D.C. plaintiff's attorney Patrick Malone discusses how he secured a $3.6 million verdict on behalf of a two-week-old baby girl who suffered a serious chemical burn from an intravenous line delivering liquid nutrition and antibiotics in her ankle at Georgetown University Hospital. The tip of the intravenous needle migrated into the muscle and fat, causing permanent injury that required multiple medical interventions. At trial, Malone demonstrated that the nursing staff at the hospital allowed the IV line to go unchecked, directly contributing to the severity of the burn. View/Download Trial Documents   Guest Bio: Patrick Malone Patrick Malone is a leading patient safety advocate and attorney who represents seriously injured people in medical malpractice lawsuits, product liability cases and other types of lawsuits. Mr. Malone has won a long string of exceptional verdicts and settlements on behalf of his clients. He is the co-author of an acclaimed book teaching other attorneys how to win cases: Rules of the Road: A Plaintiff' Lawyer's Guide to Proving Liability. Patrick Malone is a son of the Midwest. He grew up in an Irish Catholic family in Wichita, Kansas, the oldest of seven children. After graduating summa cum laude from the University of Kansas, he worked as a reporter for United Press International in Kansas City, then won a prestigious journalism fellowship at the University of Michigan, where he studied public health issues and wrote freelance articles for the Washington Post. Malone then worked as a medical writer and investigative reporter for the Miami Herald, where he won a number of awards, including a finalist designation for the Pulitzer Prize for a series co-authored on “dangerous doctors.” After he was accepted at Yale Law School, Malone and his wife Vicki sold their home in Miami and moved to a rental apartment in New Haven, Connecticut with their infant son. They had one more son while at Yale and a third after moving to the Washington area. At Yale, Malone won several student awards, including best “moot court” argument. He worked for a year after graduating for a prominent federal judge, U.S. District Judge Gerhard Gesell in Washington, D.C. In 1985, Patrick Malone began his career as an attorney representing seriously injured people. Read Full Bio   Show Sponsors: Legal Technology Services - LegalTechService.com Digital Law Marketing - DigitalLawMarketing.com Harris Lowry Manton LLP - hlmlawfirm.com   Free Resources: Stages Of A Jury Trial - Part 1 Stages Of A Jury Trial - Part 2

Robert K Shin, MD, FANA, FAAN, is a graduate of Yale University and received his medical degree from the University of Pennsylvania School of Medicine. He completed a neurology residency and fellowships in neuro-ophthalmology and multiple sclerosis at the Hospital of the University of Pennsylvania. Dr. Shin is currently Professor of Neurology at MedStar Georgetown University Hospital and Director of the Georgetown Multiple Sclerosis and Neuroimmunology Center. Dr. Shin has a special interest in health disparities in multiple sclerosis (MS) as well as visual problems associated with MS and other demyelinating disorders, including neuromyelitis optica spectrum disorder (NMOSD). On today's episode, we talk about vision changes in MS and the differences between MS and some of it's common look-alike diseases, like NMOSD. https://neurology.georgetown.edu/mscenter/ Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: Gretchen@DoctorGretchenHawley.com Website: www.MSingLink.com Social: ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink

Stephanie Lafontaine , 41, breast cancer, Everett, with Dr. Filipa Lynce, Director, Inflammatory Breast Center, Dana-Farber ● After a visit with her primary care doctor, Stephanie was called back the next day fora mammogram, ultrasound, and biopsy which lead to her diagnosis of Stage 3B TriplePositive Inflammatory Breast Cancer (IBC) with PALB2 genetic mutation.● She was referred to Dana-Farber as a second opinion and ultimately ended upstaying there for treatment.● In all, Stephanie had 18 chemotherapy infusions, a modified radical mastectomy withaxillary lymph node dissection, 30 rounds of radiation, and 15 chemo/anti HER-2infusions.● Though she is no longer in treatment, she still receives infusions every six weeks toreduce the risk of bone metastasis or osteoporosis and will take aromatase inhibitorsfor another 7 1⁄2 years.● On the horizon, she expects to go through several additional surgeries, including apreventive mastectomy, double DIEP flap reconstruction and a lymph node transfernext winter.● She says that her care team at Dana-Farber has a very “can-do” attitude and is one ofthe only IBC dedicated centers in the country.● Stephanie loves hanging out with her two cats, Tiger and Dusky. She works as amechanical engineer designing HVAC, plumbing, and fire detection systems forbuildings.● She loves travel, underwater photography, and scuba diving, notably completing her100th dive this past March. She has seen a great white shark off Guadeloupe Islandin Mexico. Breast cancer facts● Inflammatory breast cancer is a rare and very aggressive disease in which cancercells block lymph vessels in the skin of the breast. This type of breast cancer is called“inflammatory” because the breast often looks swollen and red, or inflamed.● Inflammatory breast cancer is rare, accounting for 1 to 5 percent of all breast cancersdiagnosed in the United States.● Inflammatory breast cancer progresses rapidly, often in a matter of weeks ormonths. At diagnosis, inflammatory breast cancer is either stage III or IV disease,depending on whether cancer cells have spread only to nearby lymph nodes or toother tissues as well. Dr. Filipa Lynce● Dr. Lynce received her medical degree from the Universidade Nova de Lisboa,Portugal in 2004. She completed her residency in Internal Medicine and fellowship inHematology and Medical Oncology at MedStar Washington Hospital Center/MedStarGeorgetown University Hospital in Washington, DC.● She was faculty at MedStar Georgetown University Hospital from 2015 to 2020where she served as the institutional PI for Alliance and the co-PI for the NationalCapital Area (NCA) Minority/Underserved NCORP.● In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham andWomen's Hospital, where she is a medical oncologist and clinical investigator in theBreast Oncology Center. Her research focuses on inflammatory breast cancer,triple-negative breast cancer, BRCA-associated breast cancers and novel therapies inthe treatment of breast cancer.

Women are roughly 3 times more likely to develop MS compared to men. But when men develop MS, they're more likely to experience a more aggressive disease course. Men are more likely to experience motor problems, loss of coordination and balance, and cognitive difficulties. When they experience a relapse, men are more likely to see their exacerbated symptoms continue, even during times of remission. Given these evidence-based observations, it seems sadly ironic that, as they develop MS symptoms, men are less likely to seek medical care or even a diagnosis. Dr. Robert Shin returns to the podcast to demystify some of the riddles surrounding men and MS. Dr. Shin is a Professor in the Department of Neurology at MedStar Georgetown University Hospital, and the Director of the Georgetown Multiple Sclerosis and Neuroimmunology Center. We're also sharing the registration details for the National MS Society's webcast, What Does the New Drug Pricing Law Mean to You?. The webcast takes place this Thursday, and you won't want to miss it. We'll tell you about a study that may have identified an imaging biomarker that can predict future MS progression. (And we'll explain why that can make a huge difference in your MS treatment plan) We'll share some discouraging news about the availability of Evusheld in the U.K. We'll point you toward Elizabeth Jameson's Washington Post editorial that explains how learning to swear can be therapeutic for someone living with progressive MS. And we'll share results from a Cleveland Clinic study that shows how a man's own definition of masculinity can get in the way of his MS treatment. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: MS and Men  :22 Find out how and when the Inflation Reduction Act will impact the cost of your prescription drugs  1:41 Study demonstrates that thinning of retinal layers predicts future MS disability  2:35 U.K. opts not to buy Evusheld  5:17 Elizabeth Jameson learns the value of a well-intentioned F-bomb  6:35 Study shows how masculine ideals drive healthcare decisions for men with MS  8:39 Dr. Robert Shin discusses the specifics associated with Men and MS  12:52 Share this episode  30:56 Download the RealTalk MS app for your iOS or Android device   31:16 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/260 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com National MS Society COVID-19 Vaccine Guidance for People Living with MS https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance Registration for National MS Society Webcast: What Does the New Drug Pricing Law Mean to You? https://nmss.zoom.us/webinar/register/WN_auRCXBi2TGCgzHeV1CWMkw STUDY: Retinal Thinning After Optic Neuritis is Associated with Future Relapse Remission in Relapsing Multiple Sclerosis https://neurology.org/content/early/2022/08/01/WNL.0000000000200970 Elizabeth Jameson in the Washington Post: How I Learned that Swearing Can Be Good for the Soul https://wapo.st/3vpRJeo STUDY: Effects of Conformity to Masculine Norms and Coping on Health Behaviors in Men with Multiple Sclerosishttps://doi.org/10.7224/1537-2073.2020-116 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 260 Guest: Dr. Robert Shin Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS Privacy Policy  

In this edition of SSAT Mentor of the Month, Dr. Young K. Hong, a member of the SSAT Resident and Fellow Education Committee, and Assistant Professor of Surgery and Assistant Director of Surgical Research in the Division of Surgical Oncology of the Department of Surgery at Cooper University Health Care in Camden, NJ, interviews Dr. Jason Hawksworth. Dr. Hawksworth is Chief of Robotic Surgery at MedStar Georgetown University Hospital, and an experienced, board-certified transplant and minimally invasive hepatobiliary surgeon with additional expertise in liver, kidney, and intestinal transplant surgery. He is the only surgeon in the Washington, DC, metropolitan area and one of the few in the country who performs robotic surgery to treat benign and malignant liver, pancreas, and bile duct tumors. A graduate of the United States Military Academy, West Point, Dr. Hawksworth has served in three combat tours in Afghanistan on a Forward Surgical Team. He earned his medical degree from Wake Forest Bowman Gray School of Medicine and completed his internship and residency at Walter Reed Army Medical Center. He completed his fellowship in hepatobiliary and multi-organ transplant surgery at MedStar Georgetown Hospital. Dr. Hawksworth is an active researcher focused on hepatobiliary surgery outcomes and intestinal transplantation

SHOW NOTES4:35 – 35th wedding anniversary5:25 – key qualities to a strong and meaningful relationship6:00 – team approach6:45 – facing unexpected fears, head on, one day at a time7:25 – discovering inner strength7:55 – Olivia, the amazing daughter and sister9:05 – Special Love, Inc., Tom and Sheila Baker9:35 ­– BRASS Camp11:10 – Ryan, first cancer diagnosis at two years old11:35 – ordinary family with an extraordinary circumstance11:50 – leukemia meets it match with Ryan's grit15:00 ­– choosing hope is choosing life15:15 – Make-a-Wish trips16:15 – leading through advocacy17:05 – management is key17:45 – gratitude for such remarkable support – it kept us going, it keeps us going19:25 – Camp Fantastic (Special Love, Inc.)20:15 – no one wants to join the club of parents of children with cancer21:00 – adult skills learned as a child through trial and error23:30 – rhythm of life, impact on traditions, a roller coaster of life24:35 – bringing home a puppy in the midst of the challenges25:45 – ready to go to the hospital on a moment's notice27:10 – selecting quotations that capture the essence of one's thoughts and intended message29:05 – meeting Ryan's bone marrow donor, Scott Harris31:05 – consider joining the bone marrow registry32:00 – graft versus host disease can be deadly32:40 – Sharon and Lee Johnson, the ultimate role models and friends35:15 – manufacturing sunshine36:00 – Ryan's loud pants37:05 – writing a second book (Joyride Journeys)38:30 – naming our cars and upcoming cross-country driving trip39:20 – post-traumatic growth and gains40:05 – how do we channel our loss?41:40 – advocate for yourself Focused Fight bookRyan's speechCamp FantasticBone Marrow Registry Terri's websitePost-Traumatic Growth articleMusic for Lead. Learn. Change. is Sweet Adrenaline by Delicate BeatsPodcast cover art is a view from Brunnkogel (mountaintop) over the mountains of the Salzkammergut in Austria, courtesy of photographer Simon Berger, published on www.unsplash.com.Professional Association of Georgia Educators  David's LinkedIn page

In this episode of the PRS Global Open Keynotes Podcast, Gabriel del Corral MD and Abigail Tirrell BS discuss facial feminization surgery and patient outcomes. This episode discusses the following PRS Global Open article: “Facial Feminization Surgery: A Systematic Review of Perioperative Surgical Planning and Outcomes” by Gabriel del Corral, Abigail Tirrell, Areeg Abu El Hawa, Jenna C. Bekeny, and Brian L. Chang. Read the article for free on PRSGlobalOpen.com: https://bit.ly/FacialFeminizationSurgery Dr. Gabriel del Corral is a board-certified plastic surgeon as Associate Professor of plastic surgery at Medstar Georgetown University Hospital and the Director of the Medstar Centre for Gender Affirmation in Washington, D.C. Abigail Tirrell is a fourth-year medical student at Georgetown University Medical School in Washington, D.C. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Surgery at the University of Sydney in Australia. #PRSGlobalOpen #KeynotesPodcast #PlasticSurgery

In this episode of the PRS Global Open Keynotes Podcast, Gabriel del Corral MD and Abigail Tirrell BS discuss facial feminization surgery and patient outcomes. This episode discusses the following PRS Global Open article: “Facial Feminization Surgery: A Systematic Review of Perioperative Surgical Planning and Outcomes” by Gabriel del Corral, Abigail Tirrell, Areeg Abu El Hawa, Jenna C. Bekeny, and Brian L. Chang. Read the article for free on PRSGlobalOpen.com: https://bit.ly/FacialFeminizationSurgery Dr. Gabriel del Corral is a board-certified plastic surgeon as Associate Professor of plastic surgery at Medstar Georgetown University Hospital and the Director of the Medstar Centre for Gender Affirmation in Washington, D.C. Abigail Tirrell is a fourth-year medical student at Georgetown University Medical School in Washington, D.C.. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Surgery at the University of Sydney in Australia. #PRSGlobalOpen #KeynotesPodcast #PlasticSurgery

Transitioning Into Unchartered Territory In this episode, we chat with Dr. Carrie Pagliano, a physical therapist for postpartum women about her transition from working solely in a brick and mortar 1:1 setting to incorporating a business model that can scale online. Carrie always knew she wanted to have a positive impact on women and when she realized she could reach more people and have an even greater impact in the online space, she was all for it. She just wasn't prepared for everything that went with owning your own online business, even after successfully running a private practice.   In This Episode You'll Learn: What helped Carrie the most when scaling her online business Why she chose her business model How the coaching she gets inside Scale to Seven® has helped her   Featured on the Show: Dr. Carrie Pagliano has been a dynamic leader in clinical care and education in the areas of women's/pelvic health and orthopedics for nearly 20 years. Dr. Pagliano received her Masters in Physical Therapy from the University of the Sciences in Philadelphia in 1999 and Doctor of Physical Therapy from the University of St. Augustine for Health Sciences in 2007. Dr. Pagliano is a double Board Certified Clinical Specialist in Orthopaedics and Women's Health and holds Manual Therapy Certification from the University of St. Augustine for Health Sciences. Dr. Pagliano is the founder of Carrie Pagliano PT, LLC. For over 10 years she was the program lead/founder for the Pelvic Physical Therapy clinical program/physical therapy residency at MedStar Georgetown University Hospital in Washington, DC. You can find her at: https://carriepagliano.com/ @carriepagliano Active Mom Podcast Scale to Seven®   Let's Connect Glean from our library of CEO resources at kathrynbinkley.com Connect with Kathryn on Instagram!   Listen + Subscribe on Apple Podcasts or Stitcher!  We'd greatly appreciate a podcast rating and review so we can reach more entrepreneurs like you! Search for the podcast in your podcast app (Scale to Seven®) Scroll down and click 5 stars Tap “Write a Review” & enter a brief review Press send

Most people believe you don't need to get a colonoscopy until you're 51.Most people believe you don't need to get a colonoscopy until you're 51. But colorectal cancers are the third-leading cause of cancer-related deaths in the United States, and the best way to prevent those deaths is with early detection. When are you supposed to start getting colonoscopies? And how is prep getting easier? Dr. Joseph Jennings joins us today to set the record straight.Dr. Joseph Jennings is a board-certified gastroenterologist with a focus on bleeding within the GI tract. He graduated from Georgetown University School of Medicine in 2012 and completed his Internal Medicine training at MedStar Georgetown University Hospital in 2015. He served as the Chief Medical Resident for MedStar Georgetown University Hospital and served as an attending physician in Internal Medicine at the Washington DC VA Medical Center and Virginia Hospital Center as well.He currently serves as the associate director for the MedStar Georgetown University Hospital's gastroenterology fellowship program.

In this episode of the PRS Global Open Keynotes Podcast, Karen Evans MD and Romina Deldar MD discuss the efficacy of incisional negative pressure wound dressings in patients undergoing combined panniculectomy and ventral hernia repair. This episode discusses the following PRS Global Open article: “Negative Pressure Wound Therapy Prevents Hernia Recurrence in Simultaneous Ventral Hernia Repair and Panniculectomy” by Romina Deldar, Areeg A. Abu El Hawa, John D. Bovill, Dionisio Hipolito, Eshetu Tefera, Parag Bhanot, Kenneth L. Fan and Karen K. Evans. Read the article for free on PRSGlobalOpen.com: https://bit.ly/PreventingHerniaRecurrence Dr. Karen Evans is a Professor, Associate Program Director, and the Vice Chair of Education in the Department of Plastic Surgery at MedStar Georgetown University Medical Centre in Washington DC. Dr. Romina Deldar is a general surgery resident and plastic surgery research fellow at Medstar Georgetown University Hospital in Washington DC. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Surgery at the University of Sydney in Australia. #PRSGlobalOpen #KeynotesPodcast #PlasticSurgery

In this episode of the PRS Global Open Keynotes Podcast, Karen Evans MD and Romina Deldar MD discuss the efficacy of incisional negative pressure wound dressings in patients undergoing combined panniculectomy and ventral hernia repair. This episode discusses the following PRS Global Open article: “Negative Pressure Wound Therapy Prevents Hernia Recurrence in Simultaneous Ventral Hernia Repair and Panniculectomy” by Romina Deldar, Areeg A. Abu El Hawa, John D. Bovill, Dionisio Hipolito, Eshetu Tefera, Parag Bhanot, Kenneth L. Fan and Karen K. Evans. Read the article for free on PRSGlobalOpen.com: https://bit.ly/PreventingHerniaRecurrence Dr. Karen Evans is a Professor, Associate Program Director, and the Vice Chair of Education in the Department of Plastic Surgery at MedStar Georgetown University Medical Centre in Washington DC. Dr. Romina Deldar is a general surgery resident and plastic surgery research fellow at Medstar Georgetown University Hospital in Washington DC. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Surgery at the University of Sydney in Australia. #PRSGlobalOpen #KeynotesPodcast #PlasticSurgery